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Abstract
The Stories and Music for Adolescent/Young Adult Resilience during Transplant (SMART) study
(R01NR008583; U10CA098543; U10CA095861) is an ongoing multi-site Children’s Oncology
Group randomized clinical trial testing the efficacy of a therapeutic music video intervention for
adolescents/young adults (11–24 years of age) with cancer undergoing stem cell transplant.
Treatment fidelity strategies from our trial are consistent with the NIH Behavior Change
Consortium Treatment Fidelity Workgroup (BCC) recommendations and provide a successful
working model for treatment fidelity implementation in a large, multi-site behavioral intervention
study. In this paper we summarize 20 specific treatment fidelity strategies used in the SMART
trial and how these strategies correspond with NIH BCC recommendations in 5 specific areas: 1)
study design, 2) training providers, 3) delivery of treatment, 4) receipt of treatment, and 5)
enactment of treatment skills. Increased use and reporting of treatment fidelity procedures is
essential in advancing the reliability and validity of behavioral intervention research. The SMART
trial provides a strong model for the application of fidelity strategies to improve scientific findings
and addresses the absence of published literature illustrating the application of BCC
recommendations in behavioral intervention studies.
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Introduction
The primary goal of treatment fidelity is to increase scientific confidence that changes in
targeted outcomes are due to the intervention under investigation. Treatment fidelity
includes methodological strategies that enhance reliable and consistent behavioral
intervention delivery during clinical trials [1,2]. Historically, the concept of treatment
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fidelity was conceptualized as “treatment integrity,” which examined whether an
intervention was delivered as designed [3]. Over the years, the definition of treatment
fidelity has expanded to incorporate three additional concepts including “treatment
differentiation,” whether study conditions differed from one another in the intended manner;
“treatment receipt,” whether participants understood or used the intervention skills during
sessions; and “treatment enactment,” whether study participants used skills learned during
the intervention in their daily life outside the study environment [3–5].
Treatment fidelity is vitally important to the design and implementation of behavioral
intervention research because it influences investigators’ ability to address a wide range of
study issues, including the ability to: 1) draw accurate conclusions about intervention
efficacy, 2) replicate studies, 3) identify essential features of an intervention, 4) reduce
random and unintended intervention variability to improve statistical power, 5) test
theoretical questions, and 6) disseminate and translate clinical findings [1–3,6]. Despite their
importance, treatment fidelity strategies are inconsistently used and rarely reported [2,3].
Reasons for limited reporting are difficult to determine; however, Borelli and colleagues
speculate that reasons may include poor implementation by the researchers, lack of reporting
despite satisfactory implementation, or journal editorial policies [2].
In 2004, the Treatment Fidelity Workgroup of the National Institutes of Health (NIH)
Behavior Change Consortium (BCC) published recommendations to encourage more
consistent incorporation of treatment fidelity strategies into behavioral intervention research.
The recommendations describe 5 components of treatment fidelity including: 1) study
design, 2) provider training, 3) treatment delivery, 4) treatment receipt, and 5) enactment of
treatment skills. Published manuscripts describing successful implementation of BCC
treatment fidelity recommendations will help investigators interpret the guidelines and
design strategies for their own studies, encouraging greater adoption of the proposed
guidelines. However, published examples of BCC implementation are currently limited [6–
8]. The purpose of this paper is to define and describe treatment fidelity strategies being
used in a multi-site phase II behavioral intervention study. Treatment fidelity strategies from
our trial are consistent with the NIH BCC Treatment Fidelity Workgroup recommendations
and provide a working model for successful treatment fidelity implementation in a large,
multi-site behavioral intervention study.
SMART Trial Study Overview
The Stories and Music for Adolescent/Young Adult Resilience during Transplant (SMART)
study (R01NR008583; U10CA098543; U10CA095861) is an ongoing multi-site Children’s
Oncology Group randomized clinical trial testing the efficacy of a therapeutic music video
(TMV) intervention against a low-dose audio-book control condition for adolescents/young
adults (AYA) undergoing stem cell transplant. The Resilience in Illness Model (RIM)
provides the theoretical framework that guides evaluation of the intervention (see Table 1
for dependent variables). Participants complete measures at baseline, immediately post-
intervention, and 100-days post-transplant. Throughout the study period, investigators at 6
children’s hospitals and 3 adult hospitals across the United States have accrued participants
and delivered the intervention and comparison protocols.
The TMV is a 6-session intervention (2 sessions/week over three weeks) that uses
songwriting and video production to encourage self-reflection and communication about
what is important to the AYA. The intervention is structured to accommodate the anticipated
occurrence of treatment-related symptoms, such as fatigue, pain, and mucositis, by
clustering active intervention activities such as brainstorming, songwriting, and voice
recording during the first 3 sessions and more passive activities such as picture selection and
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storyboarding during the last 3 sessions. The low-dose audio-book control condition was
structured to parallel the timing, duration, and individual therapist contact of the TMV
intervention. During the low dose audio-books condition, AYA choose audio-recorded
books from a standardized list of selections. Participants then listen to the recording and
have the opportunity to discuss their impressions about the book content with a trained
intervener. The intervention team is comprised of 14 board-certified music therapists
(referred to as interveners), who deliver the 6-session manualized intervention and a low
dose control conditions to adolescents/young adults, 11 – 24 years of age, undergoing stem
cell transplant for an oncology condition. Prior to study implementation, the core
investigative team established comprehensive treatment fidelity procedures.
Procedures
In this paper we describe SMART trial treatment fidelity strategies, organized through the
framework of the NIH BCC Treatment Fidelity recommendations. Table 2 provides
definitions for each of the 5 treatment fidelity components proposed by the NIH BCC.
Subsequently, we describe specific strategies employed in the SMART trial for each
treatment fidelity component.
1. Study Design
According to the BCC, study designs play an essential role in treatment fidelity. Three study
design features that specifically enhance treatment fidelity include: 1) the use of theory to
guide intervention design and the selection of variables, 2) specifications about treatment
dose within and across study conditions, and 3) advanced planning for implementation
setbacks. Table 3 summarizes study design goals, with corresponding strategies employed in
the SMART Trial.
Ensure interventions are congruent with relevant theory and clinical
experience—The SMART trial integrates two theoretical models - one model to inform
intervention design, and a second model to describe the problem and inform outcome
measures. Robb’s Contextual Support Model of Music Therapy provides a model for the
intervention [9,10]. Based on motivational coping literature and clinical experience, Robb’s
model specifies “essential” elements of the music-based video intervention and how they
function to improve resilience outcomes identified in Haase’s Resilience in Illness Model
[11–14]. Similarly, Robb’s model guided design of the low dose condition, which controls
for 3 nonspecific treatment effects including personal attention, audio stimulation, and
structured time. The Haase Resilience in Illness Model (RIM) describes the mechanisms for
the phenomena we are targeting – how to increase protective factors and decrease risk
factors associated with positive health outcomes in adolescents and young adults (AYA)
undergoing stem cell transplant for cancer. The RIM describes possible mechanisms that
explain improvement in positive health outcomes for AYA during cancer treatment and
provides a validated measurement model to evaluate study outcomes [11–15].
Ensure same treatment dose within and across conditions—There are four
treatment dose specifications in the SMART trial that ensure consistency within and across
the intervention and low dose conditions (see Table 3). Dosing is monitored using secure,
web-based field notes that interveners complete on desk-top computers after completing
each session. Interveners record the session date, time the session began and ended, and the
amount of time the patient reported working on study-related activities between sessions
(See Figure 1).
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Plan for implementation setbacks—When a study site has only one trained intervener,
it is vulnerable to lapses in recruitment and/or intervention delivery due to intervener illness,
vacation, schedule conflicts, or changes in job status. In order to avoid potential disruptions
we train and maintain a minimum of two interveners for each study site.
2. Training Providers (Interveners)
A second component of treatment fidelity is the use of standardized training programs to
ensure consistent delivery of study protocols across interveners and sites. The necessity for
standardized training is obvious in large behavioral intervention studies requiring multiple
interveners who have different educational and clinical backgrounds. Table 4 summarizes
intervener training goals and corresponding SMART strategies. (Note: in the SMART trial
we refer to providers as interveners and use this term in the subsequent discussion).
Standardize training—Many behavioral researchers standardize treatment and control
condition protocols, but rarely describe standardization of training [2]. Behavioral
intervention trials can take several years to complete, creating an elevated risk for intervener
turnover and repeated training for new personnel. Standardizing protocol training assures
that interveners have equivalent training experiences and are equipped to consistently
deliver study protocols regardless of when they join the study team. In the SMART trial all
interveners receive a study manual and attend a 2-day, 12-hour training session. The study
manual includes two categories of information: 1) generic study-related information, and 2)
intervener-specific information. Table 5 summarizes study manual content. Training session
content is also standardized and delivered by members of the study’s executive team.
SMART intervener training is comprehensive and includes nine major topics (see Table 4).
Ensure provider skills acquisition and minimize drift—Role playing music video
and low dose protocols is an essential training feature that helps trainers evaluate intervener
competence, readiness to deliver study conditions, and the need for individualized
instruction. After training, interveners participate in bimonthly intervention team conference
calls to discuss on-going cases, answer questions, and review study protocol procedures.
To minimize “drift” over time, our study team implemented quality assurance monitoring
procedures that include criteria for evaluating intervener adherence in delivering both
intervention and low dose control protocols. Quality assurance procedures include self-
monitoring and external monitoring. All study sessions are audio-recorded, encrypted, and
uploaded to a secure, web-based server that can only be accessed by the intervener and
external monitor. Self-monitoring procedures require that interveners listen to their audio-
recorded session and simultaneously complete a session-specific checklist that specifies
essential elements of each study session (See Figure 2). Similarly, an external monitor
listens to an intervener’s audio-recorded session and completes the same session-specific
checklist. External QA monitoring is conducted by two primary investigators who are PhD-
prepared, board-certified music therapists.
Self- and external monitoring are completed for the first 5 participants randomized to each
condition. Individual phone meetings are scheduled to discuss any quality assurance
discrepancies. If there are minimal to no discrepancies during initial monitoring, self- and
external monitoring are completed for every 5th participant enrolled in each condition. If
there continue to be discrepancies or if an intervener has not conducted sessions for 2
months, self- and external monitoring is completed for the next enrolled participant.
Accommodate provider differences—This ongoing, individualized form of training
and professional supervision is one way we accomplish the fourth goal of intervener
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training, which is to accommodate intervener differences in experience, skill, and
background. Intervener differences have also been minimized by developing a clear position
description that specifies intervener qualifications. All interveners must hold a bachelor’s
degree (or its equivalent) in music therapy from an American Music Therapy Association-
accredited program and hold board certification through the Certification Board for Music
Therapists. In addition, interveners must have training and experience in delivering music-
based interventions that are grounded in a cognitive-behavioral approach to therapy.
3. Delivery of Treatment
The third component of treatment fidelity is the use of strategies to ensure that treatment is
delivered as intended. Primary strategies include standardization of treatment protocols and
monitoring intervention delivery. Table 6 summarizes treatment delivery goals, with
corresponding SMART strategies.
Control for provider differences—The first goal of treatment delivery is to monitor and
control for nonspecific treatment effects that might result from intervener-specific traits or
common factors, such as personality or interaction style. We use five strategies to control for
intervener-specific traits that are listed in Table 6. As previously described, all intervener
sessions are audio-recorded to monitor protocol adherence, including monitoring therapist
attributes that have been shown to contribute to positive outcomes such as warmth, empathy,
and respect for the patient [16]. Our second strategy is to observe the interaction style of
potential interveners during job position interviews. We hired individuals who demonstrated
desired attributes such as warmth and active listening. In addition, we hired individuals who
had previous clinical work experience with adolescents and young adults. The goal of our
third strategy is to minimize therapist effects across study conditions by training interveners
to deliver both the intervention and low dose conditions. Although this introduces a potential
threat for therapist bias it controls for differences in discipline-specific background and
training. We also have a minimum of two interveners per study site, which allows us to
rotate interveners across study participants. Finally, we use post-study qualitative interviews
to monitor non-specific therapist effects reported by patients and parents post-intervention.
During these interviews, parents and patients are asked to describe their experience with
their assigned study condition.
Reduce differences within treatment/ensure adherence to protocol—Strategies
to reduce differences within treatment and ensure intervener adherence to protocols are
similar and include the use of manualized protocols for the intervention and low dose
control conditions, audio-recorded sessions to facilitate quality assurance (QA) monitoring,
and standardized QA checklists to monitor protocol adherence. The “gold standard” for
ensuring adequate treatment delivery is to evaluate sessions based on a priori criteria using
direct observation or recorded sessions. In the SMART trial all sessions are audio-recorded
and then evaluated for adherence using a standardized quality assurance monitoring form.
As previously described, we use two types of QA monitoring: self-evaluation and external
monitoring. Requiring interveners to listen to their own sessions and complete session-
specific QA checklists helps interveners advance their own skills by heightening their
awareness of protocol deviations and more subtle aspects of intervention delivery including
timing, word choice, and interaction style. Self-evaluation also serves to reinforce essential
content that needs to be delivered in each session.
Minimize contamination between conditions—The fourth goal of treatment
monitoring is to minimize contamination between conditions, especially when treatment and
control conditions are delivered by the same provider. Cross-contamination occurs when a
study participant in the control condition receives components from the treatment condition.
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Five of the previously described SMART strategies also help control for cross-
contamination; these strategies are summarized in Table 6.
4. Receipt of Treatment
Unlike the previous aspects of fidelity focused on how the treatment is delivered, receipt of
treatment focuses on patients and their ability to perform protocol-related skills. If a patient
does not understand or is unable to perform skills presented in the intervention protocol, an
otherwise effective intervention may be incorrectly identified as ineffective [1]. Similarly, if
patients are unable to perform low dose condition skills, the study is at risk for inadequate
controls and may lead to erroneous findings. Table 7 summarizes treatment receipt goals,
with corresponding strategies from the SMART trial.
Ensure participant comprehension and ability to use/perform skills—
Interveners are trained to assess patient comprehension through active questioning and
performance of study-related activities through behavioral observation. Interveners
document their observations and assessments using a secure, web-based field note entry.
The field note includes a 9-item, Likert-type scale to assess behavioral indicators of patient
engagement and space for a narrative entry (See Figure 1). Behavioral engagement includes
patient participation (i.e., attentive), comprehension (i.e., understood directions), and effort
(i.e., tried hard). Narrative notes summarize patient response to study conditions, social or
environmental factors that may influence treatment receipt (e.g., family or friends present in
the room; number of interruptions), and patient or family member comments. Narrative
notes augment information from the behavioral engagement items and provide information
that can be used to interpret response to treatment.
5. Enactment of Treatment Skills
Fidelity strategies for enactment of treatment focus on patients’ ability to perform treatment-
related behavioral and cognitive skills in relevant real-life settings. This is not to be
confused with treatment adherence or treatment efficacy; rather, it is specific to patients
implementing study-related skills outside of sessions. Table 8 summarizes treatment
enactment goals with corresponding strategies.
Ensure participant use of cognitive/behavioral skills—In the SMART trial we are
testing an intervention that is implemented during acute treatment for cancer. Enactment of
cognitive/behavioral skills beyond treatment sessions is not a primary aim of the
intervention, nor is it required for successful participation in study conditions. However,
opportunities for treatment skill enactment do exist and occur at two time points: 1) between
scheduled sessions, and 2) post-treatment.
Between scheduled sessions—The music video intervention relies on the participant’s
willingness and ability to engage in the creative processes of lyric writing and video design.
Interveners encourage participants to engage in independent lyric writing and video design
“homework”, but it is not required. For the low dose condition, the intervener provides
instruction and assesses the participant’s understanding of the steps needed to listen in the
intervener’s absence, but between-session listening is not required.
Post-treatment—We are conducting qualitative interviews with study participants 100
days post-transplant. Interviews will help us determine how study participants experienced
both the intervention and low dose study conditions and whether or not they continued to
use study-related skills once they completed sessions.
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To illustrate further, during the final session for our music video condition, participants view
their completed music DVD project and are given an opportunity to share their video with
family, friends, and/or healthcare providers. Enactment of study-related skills post-treatment
is not considered an essential element of the intervention we are testing, so participants are
not directed to use the DVD or study-related skills in a specified manner. Rather,
participants choose how they use their music DVD post-intervention. It is possible that
enactment of study-related skills may occur post-intervention for the intervention and low
dose control groups. Our investigative team is very interested in learning more about how
patients may be using study-related skills post-intervention; qualitative interviews will allow
us to answer these questions.
Discussion
The NIH BCC recommends that behavioral intervention researchers use strategies to address
five components of treatment fidelity. Although the BCC provides useful conceptual
descriptions of these components, the responsibility for demonstrating their successful
employment belongs to investigators who, through thoughtful design, implementation, and
evaluation strategies, work to enhance the causal inferences of their intervention studies.
The successful implementation of the guidelines requires the extensive knowledge and
creative endeavors of a multidisciplinary investigative team that can design strategies that
will create a fit with the ideographic nature of each intervention - taking into consideration
the nature of the intervention, study design, and desired outcomes. Despite the need, there
have been only a small number of published accounts that describe implementation of BCC
recommendations in a behavioral intervention trial [6–8]. In addition to this paper, each of
the aforementioned studies has defined components of treatment fidelity within the context
of the trial and described a variety of intervention and study-specific strategies used and
corresponding challenges.
Four primary challenges encountered by our study team while implementing the BCC
guidelines were: 1) clearly describing the theoretical link between the identified problem
and the intervention – explaining how the TMV would affect change in RIM latent
variables, 2) using the intervention theory to guide decisions about low-dose condition
design - identifying intervention features that needed to be controlled for through the low-
dose condition, 3) managing extended time periods between participant accrual within sites,
which resulted in additional intervener quality assurance monitoring – interveners did not
have enough opportunities to establish adherence within the timeframes specified in the QA
monitoring protocol to reduce the requisite number of monitored sessions, and 4) addressing
high intervener turn-over that resulted in more intervener training and QA monitoring. A
majority of the challenges were mitigated by identifying the challenges and problem solving
strategies during our pilot studies, which helped to decrease study start-up time, study set-
backs, and related costs. Quality assurance consistently required time and attention
throughout the study that resulted in increased study costs. However, our study team found
the vigilance was essential for overall scientific and clinical integrity of the study. Early and
consistent attention to QA monitoring helped establish a routine that was not viewed by the
team as burdensome, but as a source of professional growth and development. Our
intervention team found the QA monitoring process to be something that helped strengthen
professional skills both in and outside the study context. We found that the application and
design of strategies for some components of treatment fidelity are more ambiguous than
others. For example, “training providers” and monitoring “treatment delivery” are fairly
clear concepts, so identifying appropriate strategies is straightforward. In contrast,
components such as “treatment enactment” are less clear and may prove to be the most
challenging aspect of fidelity for investigative teams to define and monitor.
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Treatment enactment, by BCC definition, refers to the intervention skills used outside of the
study context. This is distinct from the identification of study outcomes (efficacy) or
treatment adherence. Resnick and colleagues (2005) defined it as skills required to achieve
study outcomes[6]. Radziewcz and colleagues (2009) did not use strategies to monitor
treatment enactment, stating that findings about patient preferences and engagement in the
intervention over time would ultimately characterize fidelity for enactment [8]. In our trial,
we monitored patient-initiated engagement in study-related activities between scheduled
sessions as an indicator of treatment enactment. These variations demonstrate the
importance of having investigative teams interpret, define, and identify strategies within the
context of their own study.
In summary, ensuring treatment fidelity through the BCC recommendations requires
thoughtful application – balancing realities of the clinical world with rigorous study design.
However, the effort dedicated to the design of effective strategies will assist in protecting the
internal validity of the study. We have presented one model for the application of fidelity
strategies to improve the scientific findings.
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Figure 1.
Intervener Field Note
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Figure 2.
Intervener Quality Assurance Checklist
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Table 1
Resilience in Illness Model Latent Variables and Components
RIM Latent Variables Components
1 Illness-related Distress Uncertainty in Illness
Symptom-related Distress (pain, anxiety, fatigue, mood)
2 Family Environment Family Adaptability/Cohesion, Family Communication
3 Perceived Social Support Perceived Social Support from Friends
Perceived Social Support from Health Care Providers
4 Defensive Coping Evasive, Emotive, Fatalistic
5 Positive Coping Confrontive, Optimistic, Supportant
6 Derived Meaning Hope and Spiritual Perspective
7 Resilience Confidence, Self-Esteem, Self-Transcendence
8 Quality of Life Sense of Well-being
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Table 2
Treatment Fidelity Components and Definitions*
Treatment Fidelity Component Definition
Study Design Study design procedures ensure that a study can adequately test its hypotheses in relation to underlying
theory and clinical practices.
Training Providers Standardized provider training includes procedures to ensure that interventionists have been satisfactorily
trained to deliver the intervention to study participants.
Delivery of Treatment Treatment delivery procedures monitor and improve delivery of intervention and comparison conditions;
ensuring that treatment is delivered as intended.
Receipt of Treatment Treatment receipt focuses on the participant and includes procedures to assure that the treatment was both
received and understood.
Enactment of Treatment Skills Enactment of treatment skills includes processes to monitor and improve participant ability to perform
treatment-related behavioral skills and cognitive strategies in relevant real-life settings as intended.
*
Bellg et al. (2004). Enhancing treatment fidelity in health behavior change studies: Best practices and recommendations for the NIH Behavior
Change Consortium. Health Psychology, 23(5), 443 – 451.
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Table 3
Treatment Fidelity Strategies for Study Design
Goal NIH BCC Description SMART Strategies
Ensure that
interventions are
congruent with relevant
theory and clinical
experience.
Operationalize interventions to reflect
theory; define independent and dependent
variables most relevant to the “active
ingredient” of the intervention.
Intervention Theory (Robb, 2000) “Essential” intervention
elements:
1 Structure
2 Autonomy support
3 Supportive Relationships
Theory of Problem/Measurement Model (Haase, 2004)
Ensure same treatment
dose within and across
conditions.
Ensure that treatment “dose” (measured by
number, frequency, and length of contact) is
adequately described and is the same for
each subject within and across treatment and
control conditions.
Dose specifications:
1 6 sessions
2 2 sessions/week for 3 weeks
3 60 min/session
4 Opportunities to engage in condition-related activities
outside sessions
Dose monitoring:
Web-based intervener field note:
1. Session date
2. Session begin/end time
3. Patient-reported time spent on condition-related
activities outside sessions
Dose confirmation:
1 External quality assurance monitoring
2 Audio-recorded sessions
Plan for implementation
setbacks.
Address possible setbacks in
implementation (e.g., intervener turn-over).
Train minimum of 2 interveners per study site to guarantee
intervener availability and minimize impact of turnover, vacations,
and illness.
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Table 4
Treatment Fidelity Strategies for Training Providers
Goal NIH BCC Description SMART Strategies
Standardize training. Ensure that training is conducted
similarly with different interveners.
Standardized treatment protocols/training manuals.
Standardized training session content:
1 Study overview
2 Theories underlying the problem and
intervention
3 Clinical overview of SCT and AYA
development
4 Intervention protocol training
5 Low dose condition training
6 Intervener responsibilities & workflow/
communication
7 Quality assurance procedures
8 Online database and study management
website
9 Strategies to minimize communication bias
and unblinding
Participant evaluation of training sessions.
Ensure provider skill acquisition. Train interveners to well-defined
performance criteria.
Role playing an essential feature of training.
External quality assurance monitoring until interveners
meet set criteria for adherence.
Minimize “drift” in provider skills. Ensure that intervener skills do not decay
over time (e.g., show that intervener
skills demonstrated halfway through the
intervention period are not different than
skills immediately after initial training).
External quality assurance monitoring includes periodic
checks once intervener reaches competency.
Bi-weekly intervention team conference calls.
Accommodate provider differences. Ensure adequate level of training in
interveners of differing skill level,
experience, or professional background.
Individualized supervision and monitoring.
Position description.
Minimum competencies.
Psychooncology. Author manuscript; available in PMC 2012 November 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Robb et al. Page 16
Table 5
SMART Intervener Study Manual
Generic Study-Related Information*
Standard Operating Policies/Procedures
Study Overview
Reporting/Documentation Guidelines
Communication Flowchart
Overview Adolescent/Young Adult Development
SCT treatment progression/side effects
Intervener-Specific Information
Job Description/Responsibilities
Intervention Protocol
Low Dose Control Protocol
Related Literature (theory/clinical implementation)
Quality Assurance Monitoring Forms/Procedures
*
Generic information is provided to all study personnel (i.e., project managers, co-investigators, evaluators).
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Table 6
Treatment Fidelity Strategies for Treatment Delivery
Goal NIH BCC Description SMART Strategies
Control for
provider
differences.
Monitor and control for subject perceptions
of nonspecific treatment effects (e.g.,
perceived warmth, credibility, etc. of
intervener) across intervention and control
conditions.
Audio-recorded sessions to allow supervisor feedback to interveners.
Monitor intervener interaction styles and attributes.
Hire interveners that demonstrate supportive interaction style and have
experience working with AYA.
Interveners work with both intervention and low dose condition
participants.
Conduct qualitative interviews at the end of the study.
Reduce differences
within treatment.
Ensure that interveners in the same condition
are delivering the same intervention.
Manualized intervention and low dose protocols.
Audio-recorded sessions for self and external quality assurance
monitoring.
Standardized quality assurance checklists for intervention and low
dose control conditions.
Ensure adherence
to treatment
protocol.
Ensure that treatments are being delivered in
the way in which they were conceived with
regard to content and treatment dose.
See quality assurance strategies listed above.
Review omissions and/or protocol deviations with interveners on an
individual basis.
Computerized checklists allow protocol deviation tracking across
interveners and conditions.
Minimize
contamination
between conditions.
Minimize contamination across treatment/
control conditions, especially when
implemented by same intervener.
Specific protocols for intervention and low dose conditions.
Train interveners on theory/rationale underlying structure/delivery of
low dose condition.
Train interveners to address participant questions about randomization
and their assigned condition using non-biased explanations.
Audio monitoring of protocol adherence and intervener responses to
patient/family questions about the study.
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Table 7
Treatment Fidelity Strategies for Receipt of Treatment
Goal NIH BCC Description SMART Strategies
Ensure participant comprehension. Ensure that participants understand the information
provided in intervention, especially when
participants may be cognitively compromised,
have a low level of literacy/education, or not be
proficient in English.
Intervener uses active questioning and
behavioral observation to assess patient
comprehension.
Ensure participant ability to use
cognitive skills.
Make sure that participants are able to use the
cognitive skills taught in the intervention (e.g.,
reframing, problem solving, preparing for high-risk
situations, etc.).
We use the same strategies to assess both
cognitive & behavioral skills.
Standardized documentation about patient
involvement.
Narrative summarizing patient response to
protocol and potential external factors
influencing response.
Ensure participant ability to perform
behavioral skills.
Make sure that participants are able to use the
behavioral skills taught in the intervention (e.g.,
relaxation techniques, food diaries, cigarette
refusal skills, etc.).
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Table 8
Treatment Fidelity Strategies for Enactment of Treatment Skills
Goal NIH BCC Description SMART Strategies
Ensure participant
use of cognitive
skills.
Ensure that participants actually use the
cognitive skills provided in the intervention
in appropriate life settings.
Interveners encourage participants to engage in independent
“homework” between sessions, but it is not required.
Documentation of out-of-session study-related activities.
Individual qualitative interviews are conducted with study participants
and their parents 100 days post-transplant.Ensure participant
use of behavioral
skills.
Ensure that participants actually use the
behavioral skills provided in the intervention
in appropriate life settings.
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